United Therapeutics Corporation 13D and 13G filings for Celularity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 06:00 am Unchanged |
2023-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 4.110% |
0 (Unchanged) |
Filing |
| 2023-02-06 06:01 am Unchanged |
2022-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 5.500% |
0 (Unchanged) |
Filing |
| 2023-02-03 07:28 am Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 6.510% |
796,885 (New Position) |
Filing |
| 2023-02-03 06:02 am Unchanged |
2021-07-16 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
0 0.000% |
0 (Unchanged) |
Filing |